UAB "Imunodiagnostika" Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 521,378 |
| 32,124 |
| 32,433 |
| 31,899 |
| 1,965 |
| 62.66 |
| 6.12 |
| 446,997 |
| 1,985,372 |
| 1,977,071 |
| 451,991 |
| 2024 |
|---|
| 871,720 |
| 62,940 |
| -421,468 |
| -421,468 |
| -30,431 |
| 33.98 |
| -48.35 |
| 25,528 |
| 2,475,964 |
| 2,116,563 |
| 381,595 |
| 2025 |
|---|
| 885,157 |
| 48,422 |
| -1,297,154 |
| -1,297,154 |
| -70,960 |
| 27.82 |
| -146.55 |
| 1,387,783 |
| 778,164 |
| 1,843,552 |
| 840,915 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 885,157 |
| 48,422 |
| -1,297,154 |
| -1,297,154 |
| -70,960 |
| 27.82 |
| -146.55 |
| 1,387,783 |
| 778,164 |
| 1,843,552 |
| 840,915 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
885,157 €2 % *
Sales per employee (€)
48,422 €-23 % *
Profit before tax (€)
-1,297,154 €-208 % *
Net Profit (€)
-1,297,154 €-208 % *
Profit per employee (€)
-70,960 €-133 % *
Total profitability (%)
27.82 %-18.13 % *
Net profitability (%)
-146.55 %-203.10 % *
Equity (€)
1,387,783 €5,336 % *
Amounts Payable And Liabilities (€)
778,164 €-69 % *
Non-current Assets (€)
1,843,552 €-13 % *
CurrentAssets (€)
840,915 €120 % *
